Sales & Marketing Omnichannel didn’t fail biopharma. Our metrics did. Omnichannel didn’t fail pharma. Our metrics did. In 2026, fixing that won’t be optional.
Digital How to build a measurement framework to enable digital produ... Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant portion of their revenues on digital products.
Patients Eliminating disruption with Eddy Effect metric elevates CX Between ongoing drug shortages, navigating complex insurance benefits, understanding the confusing language of
Views & Analysis How pharma can thrive in the digital era December marks the one year anniversary of the U.S.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
